≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Protozoal diseases

DOID EFO Endpoint Browser PheWeb

AB1_PROTOZOAL

toxoplasmosis: A parasitic disease contracted by the ingestion or fetal transmission of toxoplasma gondii.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

None

557745

2. Check conditions

None

557745

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — B50-B64
  • Hospital discharge: ICD-9 — 08[4-6]|130|136[3-4]|0889
  • Hospital discharge: ICD-8 — 08[6-7]|130|084|13601
  • Cause of death: ICD-10 — B50-B64
  • Cause of death: ICD-9 — 08[4-6]|130|136[3-4]|0889
  • Cause of death: ICD-8 — 08[6-7]|130|084|13601

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

1301

6. Filter based on genotype QC (FinnGen only)

1092

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 6426 2933 3386
Only index persons 5431 2564 2867
Unadjusted period prevalence (%)
Whole population 0.09 0.08 0.09
Only index persons 0.10 0.09 0.11
Median age at first event (years)
Whole population 46.07 44.91 47.33
Only index persons 44.50 43.08 45.77

-FinnGen-

Key figures

All Female Male
Number of individuals 1092 547 545
Unadjusted period prevalence (%) 0.22 0.19 0.25
Median age at first event (years) 60.33 56.51 64.16

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1142
Matched controls
11420
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
+∞
307.7
608
*
TGC00
NOMESCO Finland
Bronchial lavation
32.7
307.7
323
136
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
13.3
288.0
312
314
UGC12
NOMESCO Finland
Flexible bronchoscopy
10.8
284.3
375
496
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
12.2
233.7
261
271
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
10.5
219.3
275
334
R50.9
ICD-10 Finland
Fever, unspecified
5.7
169.4
436
1114
J18.9
ICD-10 Finland
Pneumonia, unspecified
5.1
164.2
603
2060
ZX108
NOMESCO Finland
Inhalation
33.8
158.2
102
33
XW000
NOMESCO Finland
Bone marrow biopsy
9.1
143.5
192
248
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.5
134.2
326
776
B59
ICD-10 Finland
Pneumocystosis
+∞
127.5
120
*
L03AA02
ATC
filgrastim; parenteral
10.4
127.0
150
164
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
12.2
114.4
119
108
WW500
NOMESCO Finland
Blood transfusion
7.9
111.1
164
236
GD1AD
NOMESCO Finland
Thorax CT examination
6.0
108.5
217
428
ZX120
NOMESCO Finland
Intravenous
5.2
104.7
255
599
JN4AD
NOMESCO Finland
Body CT examination
4.4
97.9
314
915
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.8
93.4
811
4501
H02AB06
ATC
prednisolone; systemic
3.6
91.3
770
4171
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
4.5
90.8
267
725
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
15.2
86.0
77
54
L04AA06
ATC
mycophenolic acid; systemic
10.9
84.0
93
92
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
8.6
83.9
112
142
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
6.2
81.1
149
268
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.8
78.3
156
303
127
Kela drug reimbursment
Transplant complication
11.9
76.0
79
71
JN4BD
NOMESCO Finland
Extensive body CT
4.1
74.8
250
739
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.6
74.7
200
500
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
11.7
72.6
76
69
D70.82
ICD-10 Finland
Drug-induced neutropenia
11.1
71.7
78
75
H32.0*B58.0
ICD-10 Finland
Toxoplasma chorioretinitis
+∞
71.6
68
*
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
10.1
71.2
83
88
H02AB02
ATC
dexamethasone; systemic
3.8
69.4
259
824
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
15.3
68.6
61
42
M04AA01
ATC
allopurinol; systemic
3.6
68.6
279
939
J01FF01
ATC
clindamycin; systemic
3.0
68.5
465
2123
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
7.3
67.6
104
155
J01MA14
ATC
moxifloxacin; systemic
4.1
66.3
209
589
L03AA13
ATC
pegfilgrastim; parenteral
5.6
65.8
135
268
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
4.2
65.8
199
544
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
17.7
65.5
54
32
A04AA01
ATC
ondansetron; systemic, rectal
4.2
65.3
202
561
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
5.8
65.2
128
244
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.2
63.9
338
1332
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
6.6
62.0
105
173
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
10.7
61.3
68
67
D70.89
ICD-10 Finland
Neutropenic splenomegaly
12.9
59.3
58
47
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.5
58.5
158
395
B50.9
ICD-10 Finland
Plasmodium falciparum malaria, unspecified
+∞
57.8
55
*
Z51.5
ICD-10 Finland
Palliative care
3.8
57.3
202
613
A03FA01
ATC
metoclopramide; systemic, rectal
2.9
57.2
386
1727
L04AX01
ATC
azathioprine; systemic
5.7
57.0
113
217
B54
ICD-10 Finland
Unspecified malaria
+∞
56.7
54
*
J01MA12
ATC
levofloxacin; systemic
3.0
55.5
331
1382
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.2
54.3
158
417
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
18.9
52.8
42
23
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
17.8
52.5
43
25
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
14.8
52.1
47
33
C03CA01
ATC
furosemide; systemic
2.6
51.5
468
2409
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.5
51.0
516
2792
L04AD01
ATC
ciclosporin; systemic
8.8
50.6
65
78
WW200
NOMESCO Finland
Immunization
6.7
49.6
81
128
JN6AD
NOMESCO Finland
CT of torso and neck
8.0
48.8
68
90
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.0
47.6
254
989
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.3
47.0
208
725
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.2
46.6
213
757
TK800
NOMESCO Finland
Hemodialysis
7.0
45.4
71
107
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
10.2
44.8
51
52
J05AB11
ATC
valaciclovir; oral
2.9
44.4
260
1061
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.5
43.1
87
169
A04AA02
ATC
granisetron; systemic, transdermal
3.7
42.7
146
430
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
39.2
351
1754
H02AB07
ATC
prednisone; oral
2.8
38.7
224
903
A41.9
ICD-10 Finland
Sepsis, unspecified
4.8
37.5
89
199
L03AA14
ATC
lipegfilgrastim; parenteral
7.0
37.2
58
87
1XC02, ,
NOMESCO Finland
12.8
36.8
36
29
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.4
35.6
72
140
L04AA01
ATC
[U] ciclosporin
9.3
35.3
43
48
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
6.8
35.1
56
86
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
6.3
34.8
60
100
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.8
34.5
112
317
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
8.5
34.4
45
55
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
8.0
32.9
45
58
ZX112
NOMESCO Finland
Subcutaneous
5.6
32.9
64
120
L04AD02
ATC
tacrolimus; systemic
9.4
32.3
39
43
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
6.3
32.1
55
91
A07AA09
ATC
vancomycin; oral
8.0
32.1
44
57
WX892
NOMESCO Finland
Monitored bed care
3.2
32.0
142
491
WZC00
NOMESCO Finland
Treatment plan or consultation
2.1
31.7
497
3071
B03XA01
ATC
erythropoietin; parenteral
9.5
31.0
37
40
Z94.0
ICD-10 Finland
Kidney transplant status
9.1
30.8
38
43
C90.0
ICD-10 Finland
Multiple myeloma
8.1
30.4
41
52
B58.9
ICD-10 Finland
Toxoplasmosis, unspecified
+∞
30.3
29
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.9
30.3
160
610
N02AA05
ATC
oxycodone; systemic
2.3
30.0
286
1446
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
8.0
29.9
41
53
13000
ICD-8 Finland
Toxoplasmosis, Acquired
+∞
29.3
28
*
B58.0
ICD-10 Finland
Toxoplasma oculopathy
+∞
29.3
28
*
A02BC02
ATC
pantoprazole; systemic
2.2
29.3
855
6561
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
28.9
279
1415
H02AB09
ATC
hydrocortisone; systemic
5.3
28.8
59
116
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
5.4
28.4
57
110
R06.0
ICD-10 Finland
Dyspnoea
2.1
28.4
390
2273
L04AX03
ATC
methotrexate; systemic
2.8
28.2
161
639
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
9.7
27.2
32
34
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.4
27.1
103
323
Z49.1
ICD-10 Finland
Extracorporeal dialysis
7.1
26.9
41
60
WF049
NOMESCO Finland
Radiotherapy of metastasis
4.1
26.7
77
200
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
4.5
26.0
65
151
B03XA02
ATC
darbepoetin alfa; parenteral
5.0
26.0
57
119
D64.9
ICD-10 Finland
Anaemia, unspecified
2.6
25.7
172
737
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
25.6
396
2390
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
3.1
25.6
114
394
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
4.7
25.5
60
133
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.3
25.2
99
317
1CX01, ,
NOMESCO Finland
39.8
25.0
31
8
A07EC01
ATC
sulfasalazine; oral, rectal
2.9
24.9
127
473
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3.3
24.9
97
309
L01BA01
ATC
methotrexate; systemic
4.1
24.1
67
169
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
7.3
23.8
35
49
WW300
NOMESCO Finland
Transfer of autologic stem cells
21.9
23.5
34
16
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.6
23.4
80
234
R4110
NOMESCO Finland
Physiotherapy
2.0
23.1
374
2278
A11CC03
ATC
alfacalcidol; systemic
4.8
23.1
53
115
J17.3
ICD-10 Finland
Pneumonia in parasitic diseases
+∞
23.0
22
*
B48.5
ICD-10 Finland
Pneumocystosis
+∞
23.0
22
*
P01BA02
ATC
hydroxychloroquine; oral
2.8
22.9
127
494
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.1
22.9
102
352
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.6
22.9
55
124
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
6.4
22.8
38
61
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
7.6
22.6
32
43
153
Kela drug reimbursment
Lenalidomid
9.2
22.1
27
30
TPH07
NOMESCO Finland
Cathetrisation of artery
2.4
22.1
177
822
Z3231
NOMESCO Finland
Registered nurse
1.9
22.0
356
2163
J05AB01
ATC
aciclovir; systemic
2.0
21.9
289
1635
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
4.5
21.7
54
125
PJA10
NOMESCO Finland
Exploration of lymph nodes
6.2
21.7
37
61
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
31.8
21.5
28
9
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
8.4
21.4
28
34
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
27.0
21.4
29
11
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
7.7
21.3
30
40
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
21.2
630
4612
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
6.3
21.2
36
59
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
8.6
21.1
27
32
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.5
21.0
52
120
WX720
NOMESCO Finland
Own respiration
3.1
20.9
90
304
H02AB04
ATC
methylprednisolone; systemic
2.2
20.8
200
1002
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.5
20.7
143
620
B01AB10
ATC
tinzaparin; parenteral
2.3
20.6
169
792
A12AA04
ATC
calcium carbonate; oral
5.5
20.5
40
75
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.5
20.3
133
562
J01MA02
ATC
ciprofloxacin; systemic
1.8
20.3
480
3270
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
20.3
169
797
L04AX04
ATC
lenalidomide; oral
8.6
20.2
26
31
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
3.8
20.2
63
173
R81
ICPC
Pneumonia
3.6
20.1
69
202
Z2446
NOMESCO Finland
Social worker
2.8
20.0
106
402
A07AA02
ATC
nystatin; oral
3.0
20.0
93
329
L01CA04
ATC
vinorelbine; systemic
7.5
19.6
28
38
6BA02, ,
NOMESCO Finland
40.9
19.5
24
6
L04AA13
ATC
[U] leflunomide
4.5
19.3
48
111
WF004
NOMESCO Finland
Palliative radiotherapy
4.7
19.3
45
99
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
46.9
19.2
23
5
ZXE00
NOMESCO Finland
One hour or less
1.8
19.2
470
3218
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.0
19.1
259
1472
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.8
19.0
102
390
M05BX04
ATC
denosumab; parenteral
2.8
18.9
100
379
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
18.9
221
1190
13099
ICD-8 Finland
Toxoplasmosis, Unspecified
+∞
18.8
18
*
1302A
ICD-9 Finland
Toxoplasmosis, Chorioretinitis due to toxoplasmosis
+∞
18.8
18
*
H32.0
ICD-10 Finland
Chorioretinal inflammation in infectious and parasitic diseases classified elsewhere
+∞
18.8
18
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
19.1
18.7
28
15
JN3AD
NOMESCO Finland
Abdominal CT examination
2.1
18.4
188
962
A05AA02
ATC
ursodeoxycholic acid; oral
5.4
18.3
36
68
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
18.3
151
708
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
18.1
438
2979
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
18.0
507
3597
N05CF01
ATC
zopiclone; oral
1.8
17.9
384
2520
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
17.7
254
1467
212
Kela drug reimbursment
Gout
4.8
17.6
40
86
N18.0
ICD-10 Finland
End-stage renal disease
6.7
17.5
28
43
N18.8
ICD-10 Finland
Other chronic renal failure
4.4
17.5
44
103
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
19.0
17.4
26
14
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.7
17.2
95
368
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.9
17.2
85
311
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.6
16.8
101
409
B02.9
ICD-10 Finland
Zoster without complication
2.5
16.8
108
452
XQ855, ,
SPAT
5.9
16.7
30
52
0840A
ICD-9 Finland
Malaria, Falciparum malaria [malignant tertian]
+∞
16.7
16
*
H30.0
ICD-10 Finland
Focal chorioretinal inflammation
+∞
16.7
16
*
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
6.6
16.7
27
42
A03
ICPC
Fever
2.0
16.5
212
1176
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
12.4
16.4
29
24
J96.0
ICD-10 Finland
Acute respiratory failure
5.1
16.3
34
68
Z3226
NOMESCO Finland
Physiotherapist
1.9
16.1
231
1330
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
16.0
319
2035
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
3.7
16.0
52
147
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
3.6
16.0
53
152
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
3.2
15.9
66
218
A46
ICD-10 Finland
Erysipelas
2.0
15.6
196
1077
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
22.4
15.6
22
10
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.4
15.6
39
91
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.6
15.5
97
400
J12.8
ICD-10 Finland
Other viral pneumonia
6.8
15.3
24
36
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
7.1
15.3
23
33
J02AC03
ATC
voriconazole; systemic
16.3
15.3
24
15
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.5
15.2
103
441
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.3
15.1
39
93
Z2221
NOMESCO Finland
Medical doctor
1.8
15.1
325
2114
L01AA02
ATC
chlorambucil; oral
20.4
15.1
22
11
I50.9
ICD-10 Finland
Heart failure, unspecified
2.0
14.9
176
947
390
Kela drug reimbursment
Ibrutinib
32.2
14.8
19
6
J01DB01
ATC
cefalexin; oral
1.9
14.7
947
8212
A04AA55
ATC
palonosetron, combinations; systemic
3.1
14.7
61
202
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
5.0
14.6
31
63
B01AB05
ATC
enoxaparin; parenteral
1.7
14.6
381
2611
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
2.5
14.5
95
400
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.2
14.5
59
193
XX3DW
NOMESCO Finland
Time consuming IT work
2.1
14.4
150
770
ZX120, ,
SPAT
5.4
14.2
28
53
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
10.2
14.0
27
27
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
12.9
13.9
24
19
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
3.9
13.9
40
104
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.7
13.8
337
2260
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.2
13.8
54
172
WW409
NOMESCO Finland
Other aferesis
20.3
13.8
20
10
M01CB01
ATC
sodium aurothiomalate; parenteral
5.4
13.8
27
51
NH3EA
NOMESCO Finland
Feet X-ray examination with load
4.2
13.5
36
88
WX002
NOMESCO Finland
Sedation and analgesia
1.8
13.4
239
1466
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.1
13.4
132
663
329
Kela drug reimbursment
Lenalidomide
11.6
13.3
24
21
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
11.6
13.3
24
21
WZC30
NOMESCO Finland
Teaching
1.9
13.3
209
1233
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
6.4
13.3
22
35
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
3.8
13.3
41
112
1512
Kela drug reimbursment
Ibrutinib
28.7
13.0
17
6
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
6.2
13.0
22
36
WX726
NOMESCO Finland
High-flow oxygen therapy
22.8
12.9
18
8
RD210, ,
NOMESCO Finland
4.6
12.9
30
66
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
12.9
271
1742
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
12.8
429
3106
B34.9
ICD-10 Finland
Viral infection, unspecified
3.5
12.8
45
134
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.7
12.7
68
259
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
12.7
307
2047
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
4.4
12.7
32
75
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.0
12.6
57
198
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
6.0
12.6
22
37
L01BB05
ATC
fludarabine; systemic
32.4
12.6
16
5
Z3229
NOMESCO Finland
Other healthcare associate professional
2.2
12.6
107
506
AA1AD
NOMESCO Finland
CT of head and brain
1.6
12.5
357
2483
J17.1*B25.0
ICD-10 Finland
Cytomegaloviral pneumonitis
+∞
12.5
12
*
TAB00
NOMESCO Finland
Lumbar puncture
2.7
12.5
66
250
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
12.5
195
1147
R03AC02
ATC
salbutamol; inhalant
1.6
12.4
620
4916
WX725
NOMESCO Finland
Noninvasive ventilation
2.5
12.4
81
341
A10AC01
ATC
insulin (human); parenteral
2.3
12.3
100
464
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.9
12.2
159
881
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
4.8
12.2
27
57
R05
ICD-10 Finland
Cough
1.7
12.0
257
1656
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.1
12.0
125
640
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.7
12.0
64
244
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
2.9
11.9
56
199
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
11.9
209
1272
H30.9
ICD-10 Finland
Chorioretinal inflammation, unspecified
47.2
11.9
14
*
YNB10
NOMESCO Finland
Collection of stem cells for transplant
47.2
11.9
14
*
WX882
NOMESCO Finland
High dependency care
3.3
11.9
45
141
R02
ICPC
Shortness of breath/dyspnoea
1.9
11.8
174
1003
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
3.1
11.8
48
157
N02AA01
ATC
morphine; systemic, rectal
3.9
11.8
35
93
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
5.2
11.8
24
47
SPAT1255
SPAT
Intravenous administration of medicine
2.3
11.8
90
407
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
11.8
808
6855
R4190
NOMESCO Finland
Nutritional therapy
2.7
11.7
62
235
399
Kela drug reimbursment
Venetoclax
16.6
11.7
18
11
ZXA00
NOMESCO Finland
Right side
1.6
11.6
308
2096
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.9
11.6
54
191
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.8
11.6
214
1322
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.7
11.6
36
99
L01AA01
ATC
cyclophosphamide; systemic
11.2
11.6
21
19
N17.8
ICD-10 Finland
Other acute renal failure
4.9
11.5
25
52
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.1
11.4
48
160
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
4.2
11.4
30
73
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
11.4
529
4101
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
9.7
11.3
22
23
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
4.8
11.2
25
53
137
Kela drug reimbursment
Uraemia requiring dialysis
5.6
11.2
21
38
B23.8
ICD-10 Finland
HIV disease resulting in other specified conditions
25.3
11.2
15
6
3AC01, ,
NOMESCO Finland
8.1
11.1
24
30
C82.1
ICD-10 Finland
Follicular lymphoma grade II
8.1
11.1
24
30
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.5
11.1
73
309
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
14.0
11.0
18
13
L01EL01
ATC
ibrutinib; oral
43.8
10.9
13
*
L01XE27
ATC
[U] ibrutinib
43.8
10.9
13
*
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
15.7
10.8
17
11
1518, ,
Kela drug reimbursment
15.7
10.8
17
11
E87.5
ICD-10 Finland
Hyperkalaemia
3.8
10.8
32
85
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
2.3
10.7
85
390
J70.2
ICD-10 Finland
Acute drug-induced interstitial lung disorders
21.7
10.7
15
7
C83.00
ICD-10 Finland
Lymphocytic lymphoma
21.7
10.7
15
7
R06AE07
ATC
cetirizine; oral
1.5
10.7
470
3585
A04AD12
ATC
aprepitant; systemic
3.6
10.7
35
100
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
3.8
10.6
32
86
M05BA04
ATC
alendronic acid; oral
2.1
10.6
103
513
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
5.1
10.5
22
44
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
10.2
10.5
20
20
RS221, ,
NOMESCO Finland
4.5
10.5
25
56
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.4
10.4
75
330
B20.6
ICD-10 Finland
HIV disease resulting in Pneumocystis jirovecii pneumonia
111.0
10.4
11
*
B55.1
ICD-10 Finland
Cutaneous leishmaniasis
+∞
10.4
10
*
1309X
ICD-9 Finland
Toxoplasmosis, unspecified
+∞
10.4
10
*
B60.8
ICD-10 Finland
Other specified protozoal diseases
+∞
10.4
10
*
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.2
10.4
88
416
L04AB04
ATC
adalimumab; parenteral
3.5
10.3
35
102
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
8.3
10.3
22
27
A10AB05
ATC
insulin aspart; parenteral
2.1
10.3
99
491
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
4.8
10.3
23
49
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.5
10.3
64
264
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
10.2
221
1424
ZXE20
NOMESCO Finland
More than three and less than five hours
1.8
10.2
165
979
L04AB01
ATC
etanercept; parenteral
4.3
10.1
26
62
J04BA02
ATC
dapsone; oral
10.1
10.0
19
19
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.1
10.0
98
490
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.2
9.9
26
63
L01XX52
ATC
venetoclax; oral
16.9
9.9
15
9
Z94.2
ICD-10 Finland
Lung transplant status
20.2
9.8
14
7
E0000UV, ,
ATC
1.5
9.7
450
3453
JN4CD
NOMESCO Finland
Very extensive body CT
2.6
9.5
53
207
UJF92
NOMESCO Finland
Capsular endoscopy
3.4
9.5
33
98
GDG10
NOMESCO Finland
Bilateral transplantation of lung
30.3
9.4
12
*
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
30.3
9.4
12
*
08410
ICD-8 Finland
Vivax malaria (benign tertian)
+∞
9.4
9
*
B51.9
ICD-10 Finland
Plasmodium vivax malaria without complication
+∞
9.4
9
*
DHA10
NOMESCO Finland
Biopsy of cavity of nose
5.2
9.4
19
37
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
21.9
9.4
13
6
ZXA05
NOMESCO Finland
Left side
1.6
9.3
270
1865
K65.0
ICD-10 Finland
Acute peritonitis
4.9
9.3
20
41
C07AB07
ATC
bisoprolol; oral
1.5
9.3
554
4456
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
9.6
9.3
18
19
L88
ICPC
Rheumatoid/seropositive arthritis
2.6
9.2
54
216
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
13.8
9.2
15
11
UJF32
NOMESCO Finland
Coloscopy
1.6
9.1
298
2114
RS220, ,
NOMESCO Finland
4.3
9.1
23
54
ZX090
NOMESCO Finland
Other technic of radiotherapy
2.8
9.1
45
165
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
4.5
9.1
22
50
N02AX02
ATC
tramadol; systemic, rectal
1.5
9.1
486
3821
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
4.8
9.1
20
42
XG410
NOMESCO Finland
Flow-volume spirometry
2.5
9.1
56
230
M31.3
ICD-10 Finland
Wegener granulomatosis
11.6
9.1
16
14
J01CA04
ATC
amoxicillin; systemic
1.6
9.1
899
7996
WW400
NOMESCO Finland
Plasmaferesis
37.0
9.0
11
*
R03AK08
ATC
formoterol and beclometasone; inhalant
2.4
9.0
60
256
ZXD05
NOMESCO Finland
Urgent procedure
1.5
9.0
329
2394
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
7.5
8.9
20
27
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.9
8.9
115
634
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
4.0
8.9
25
64
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
4.4
8.9
22
51
TQW99
NOMESCO Finland
Other minor procedure on skin
2.3
8.8
69
316
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
4.2
8.7
23
56
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
8.7
485
3833
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
3.6
8.7
28
79
N03AX16
ATC
[U] pregabalin
1.6
8.7
254
1755
J01AA02
ATC
doxycycline; systemic
1.5
8.7
853
7524
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.9
8.7
112
618
GX1K5
NOMESCO Finland
Diffusion capacity
7.7
8.7
19
25
A02BC01
ATC
omeprazole; systemic
1.5
8.6
295
2111
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
4.8
8.6
19
40
D69.5
ICD-10 Finland
Secondary thrombocytopenia
11.7
8.6
15
13
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.3
8.6
66
300
A06AD11
ATC
lactulose; oral
1.7
8.6
163
1011
S01BA04
ATC
prednisolone; ophthalmic
3.2
8.5
33
105
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
10.1
8.5
16
16
J47
ICD-10 Finland
Bronchiectasis
3.3
8.5
32
100
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.4
8.5
59
256
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.9
8.5
38
132
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
2.9
8.5
38
132
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
27.7
8.5
11
*
SPAT1262
SPAT
Handing over of treatment supplies
1.6
8.5
198
1296
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
4.3
8.4
21
49
XF600
NOMESCO Finland
Bloodpressure measurement
2.1
8.4
79
389
R11
ICD-10 Finland
Nausea and vomiting
1.9
8.4
100
537
WX402
NOMESCO Finland
General anaesthesia
1.6
8.4
254
1769
B50.0
ICD-10 Finland
Plasmodium falciparum malaria with cerebral complications
+∞
8.3
8
*
08400
ICD-8 Finland
Falicparum malaria (malignant tertian)
+∞
8.3
8
*
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
3.7
8.3
26
72
ZX121
NOMESCO Finland
Central venous catheter
10.8
8.3
15
14
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
10.8
8.3
15
14
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.9
8.3
98
525
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
3.6
8.3
27
77
GX1E5
NOMESCO Finland
Flow volume spirometry and bronchodilation test
7.1
8.3
19
27
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
14.6
8.2
13
9
Z49.0
ICD-10 Finland
Preparatory care for dialysis
4.8
8.1
18
38
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.3
8.1
30
93
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
3.4
8.1
29
88
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
8.2
8.1
17
21
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
22.2
8.0
11
5
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
4.2
8.0
21
51
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
8.0
93
495
J01FA06
ATC
roxithromycin; oral
1.5
8.0
417
3241
A06AH03
ATC
naloxegol; oral
3.6
8.0
26
74
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.4
7.9
52
220
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
7.9
222
1517
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic
4.5
7.9
19
43
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.6
7.9
205
1375
A02BC05
ATC
esomeprazole; systemic
1.4
7.9
438
3444
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
3.5
7.8
26
75
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.5
7.8
48
197
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.3
7.8
59
266
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
2.5
7.8
47
191
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
7.8
278
2002
A41.8
ICD-10 Finland
Other specified sepsis
3.1
7.7
31
101
J96.1
ICD-10 Finland
Chronic respiratory failure
3.0
7.7
33
112
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
6.0
7.7
20
34
WPB10
NOMESCO Finland
Making a convalescent care decision
7.5
7.7
17
23
V03AE01
ATC
polystyrene sulfonate; oral
3.8
7.7
23
62
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
3.0
7.6
33
113
L04AX05
ATC
pirfenidone; oral
11.9
7.6
13
11
R03BB04
ATC
tiotropium bromide; inhalant
1.8
7.6
120
706
356
Kela drug reimbursment
Nintedanib and pirfenidone
8.9
7.6
15
17
L04AA24
ATC
abatacept; parenteral
10.1
7.5
14
14
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.3
7.5
53
232
J02AC01
ATC
fluconazole; systemic
1.4
7.5
379
2921
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.0
7.5
33
114
H04.10
ICD-10 Finland
Dry eye syndrome
1.7
7.5
130
786
J46
ICD-10 Finland
Status asthmaticus
2.9
7.4
34
120
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
3.3
7.4
27
83
SPAT1325
SPAT
Vaccination
1.5
7.4
353
2690
A08.1
ICD-10 Finland
Acute gastroenteropathy due to Norovirus
13.5
7.4
12
9
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
7.4
247
1753
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
2.3
7.4
53
234
P01AB01
ATC
metronidazole; oral, rectal
1.4
7.4
417
3279
R28
ICPC
Limited function/disability (R)
3.8
7.4
22
59
284
Kela drug reimbursment
Nintedanib and pirfenidone
8.4
7.3
15
18
V03AE02
ATC
sevelamer; oral
8.4
7.3
15
18
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.6
7.3
42
167
WX610
NOMESCO Finland
Patient controlled analgesia
6.9
7.3
17
25
13020
ICD-8 Finland
Toxoplasmosis, Late effects of intra-utrine infection
+∞
7.3
7
*
1363A
ICD-9 Finland
Other and unspecified infectious and parasitic diseases, Pneumocystosis
+∞
7.3
7
*
0846X
ICD-9 Finland
Malaria, unspecified
+∞
7.3
7
*
HA1AA
NOMESCO Finland
X-ray mammography
1.9
7.3
88
475
N19
ICD-10 Finland
Unspecified kidney failure
2.4
7.2
50
217
C08CA01
ATC
amlodipine; oral
1.4
7.2
433
3437
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
15.9
7.2
11
7
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.4
7.2
48
205
9673/3-C77.9
ICD-O-3
Mantle cell lymphoma of lymph node, NOS
30.2
7.2
9
*
B74
ICPC
Malignant neoplasm blood other
20.2
7.1
10
5
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
4.1
7.1
19
47
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.6
7.1
122
1926
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.2
7.0
60
285
130
Kela drug reimbursment
Malignant tumour
1.8
7.0
109
638
L02BG06
ATC
exemestane; oral
3.3
7.0
26
81
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
3.3
7.0
25
76
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.9
6.9
31
108
H26.3
ICD-10 Finland
Drug-induced cataract
5.9
6.9
18
31
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
13.9
6.9
11
8
TPH04, ,
SPAT
3.8
6.8
20
53
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.2
6.8
54
249
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
9.4
6.8
13
14
J12.9
ICD-10 Finland
Viral pneumonia, unspecified
6.1
6.8
17
28
ZX131
NOMESCO Finland
Intrathecal
40.3
6.8
8
*
WW402
NOMESCO Finland
Leucoferesis
40.3
6.8
8
*
120
Kela drug reimbursment
Hypogammaglobulinaemia
16.8
6.7
10
6
J15.8
ICD-10 Finland
Other bacterial pneumonia
7.2
6.7
15
21
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
3.8
6.7
20
54
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
3.8
6.7
20
54
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
12.3
6.6
11
9
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
6.6
409
3255
1CD02, ,
NOMESCO Finland
4.2
6.6
17
41
R4120
NOMESCO Finland
Occupational therapy
1.9
6.6
75
398
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
6.9
6.5
15
22
B05DB
ATC
Hypertonic solutions
6.2
6.5
16
26
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
6.2
6.5
16
26
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
2.9
6.5
30
107
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
4.0
6.5
18
46
B01AB04
ATC
dalteparin; parenteral
2.1
6.4
55
263
A28
ICPC
Limited function/disability NOS
1.5
6.4
193
1339
FM1FN
NOMESCO Finland
Heart function isotope examination
8.2
6.3
13
16
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.9
6.3
78
425
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
3.5
6.3
21
61
Z94.4
ICD-10 Finland
Liver transplant status
11.1
6.3
11
10
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
9.3
6.3
12
13
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
6.3
144
936
B37.0
ICD-10 Finland
Candidal stomatitis
3.9
6.3
18
47
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
18.1
6.3
9
5
B73
ICPC
Leukaemia
18.1
6.3
9
5
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
18.1
6.3
9
5
B53.0
ICD-10 Finland
Plasmodium ovale malaria
+∞
6.3
6
*
H30.8
ICD-10 Finland
Other chorioretinal inflammations
+∞
6.3
6
*
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
+∞
6.3
6
*
1XX08, ,
NOMESCO Finland
+∞
6.3
6
*
08499
ICD-8 Finland
Malaria, Unspecified forms
+∞
6.3
6
*
J17.3*B58.3
ICD-10 Finland
Pulmonary toxoplasmosis
+∞
6.3
6
*
ZXA10
NOMESCO Finland
Bilateral
1.5
6.2
191
1327
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.5
6.2
219
1568
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
4.0
6.2
17
43
WYA20, ,
SPAT
6.3
6.2
15
24
H05BX01
ATC
cinacalcet; oral
6.3
6.2
15
24
ZX100
NOMESCO Finland
Oral
3.3
6.2
22
67
D07AC01
ATC
betamethasone; topical
1.4
6.1
383
3043
TPX15
NOMESCO Finland
Removal of vascular injection port
7.7
6.1
13
17
ZX070
NOMESCO Finland
Intensity modified radiotherapy
2.9
6.1
27
94
WX721
NOMESCO Finland
Oxygen concentrator therapy
10.1
6.0
11
11
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
10.1
6.0
11
11
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
3.5
6.0
20
58
WX704
NOMESCO Finland
Intubation
1.8
6.0
88
506
R03BA08
ATC
ciclesonide; inhalant
1.8
6.0
93
544
ED1AA
NOMESCO Finland
Mandibular X-ray examination
5.6
6.0
16
29

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
222
151
18.01
257.11
2.5
1.5
—
—
—
0
0
222
151
18.01
257.11
2.5
1.5
—
—
—
0
0
222
151
18.01
257.11
2.5
1.5
—
—
—
0
0
222
151
18.01
257.11
2.5
1.5
—
—
—
0
0
186
94
23.44
247.47
3.0
2.1
1062.52
1254.61
e6/l
0.82
177
84
163
85
22.20
213.29
3.7
2.9
36.31
39.79
%
0.68
97
45
399
879
6.44
183.98
6.9
2.8
8.60
10.89
g/l
10.19
390
813
462
1341
5.11
152.20
2.3
1.5
—
—
—
0
0
98
32
33.41
151.45
2.1
1.5
34.22
31.28
%
0.41
98
32
119
70
18.86
146.40
3.4
2.4
214.66
223.13
e6/l
0.10
112
62
266
493
6.73
143.77
3.1
1.9
0.95
1.99
ug/l
0.93
250
446
721
3085
4.63
140.41
11.4
4.5
—
—
—
0
0
493
1605
4.65
138.41
2.6
2.1
—
—
—
0
0
152
163
10.60
130.64
3.0
2.4
—
—
—
0
0
155
174
10.15
128.79
2.6
2.6
—
—
—
0
0
107
71
16.53
123.62
3.3
2.2
506.22
565.61
e6/l
0.18
94
59
291
710
5.16
114.97
3.3
1.8
1.05
1.48
g/l
2.54
261
661
232
472
5.91
112.38
2.7
1.6
8.36
13.82
iu/ml
0.60
15
14
473
1697
4.05
112.33
2.0
1.9
—
—
—
0
0
438
1528
4.03
107.54
14.0
6.1
1.08
1.03
mmol/l
2.00
429
1422
146
195
8.44
105.27
2.2
1.8
—
—
—
0
0
330
974
4.36
101.49
10.6
4.7
1.09
0.93
%
0.65
242
317
724
3637
3.71
100.14
19.1
6.5
—
—
—
0
0
873
4970
4.21
99.37
20.6
6.8
8.90
8.98
%
0.25
850
4669
484
1895
3.70
98.72
7.8
3.5
0.81
0.82
mmol/l
0.99
473
1787
878
5059
4.18
97.16
20.5
6.7
25.72
27.30
%
2.77
857
4809
867
4960
4.11
96.81
20.3
6.7
2.23
2.89
%
18.57
844
4663
284
781
4.51
95.36
1.8
1.5
—
—
—
0
0
73
38
20.45
94.43
1.2
1.3
—
—
—
0
0
861
4958
3.99
93.85
20.5
6.7
0.61
0.68
%
2.86
839
4651
862
4970
4.00
93.72
19.0
6.5
59.58
57.38
%
4.55
850
4759
902
5396
4.20
91.94
18.5
6.5
0.04
0.04
e9/l
2.94
828
4601
900
5382
4.17
91.64
18.6
6.5
0.62
0.59
e9/l
1.27
825
4581
908
5472
4.22
91.16
18.8
6.6
2.02
1.93
e9/l
0.19
847
4799
910
5554
4.14
88.15
20.4
6.8
0.16
0.20
e9/l
14.47
850
4843
368
1300
3.70
86.03
5.8
3.0
1.97
1.80
%
1.81
347
1178
136
210
7.22
85.93
1.5
1.4
126.12
155.02
au/ml
1.57
44
63
143
234
6.84
85.55
1.5
1.4
—
—
—
0
0
211
523
4.72
79.96
2.5
2.0
1.53
1.52
g/l
0.04
180
467
933
5984
4.06
79.33
33.5
10.1
4.18
4.15
e9/l
0.13
868
5194
333
1159
3.64
78.82
2.2
1.6
—
—
—
0
0
306
1023
3.72
76.78
5.5
3.0
72.37
70.52
e9/l
0.31
231
766
288
925
3.83
76.68
10.6
4.6
0.66
0.60
%
0.25
200
294
107
143
8.15
76.62
1.6
1.4
—
—
—
0
0
357
1329
3.45
75.71
12.2
9.1
4.82
5.11
kpa
7.41
343
1282
357
1329
3.45
75.71
12.2
9.1
10.95
12.11
kpa
4.70
341
1286
87
91
10.27
75.40
1.6
1.2
—
—
—
0
0
353
1321
3.42
74.03
12.2
9.1
7.44
7.41
ph
7.41
219
745
625
3265
3.02
73.14
12.2
4.3
7.40
7.40
ph
1.25
510
2337
349
1312
3.39
72.46
11.9
9.1
1.10
0.97
mmol/l
0.25
291
1087
282
926
3.72
72.29
11.2
4.8
0.16
0.11
%
0.59
194
270
130
231
6.22
71.40
6.5
4.1
—
—
—
0
0
125
221
6.23
68.95
1.4
1.3
259.35
257.87
u/ml
0.02
83
128
362
1443
3.21
67.59
1.9
1.6
—
—
—
0
0
780
4730
3.05
67.27
13.4
5.4
33.48
35.52
g/l
16.35
753
4466
150
323
5.19
66.81
1.4
1.3
—
—
—
0
0
458
2115
2.95
65.54
4.6
2.9
519.34
541.73
mosm/kgh2o
1.72
441
1860
90
118
8.19
65.34
2.5
2.4
40.60
42.89
iu/ml
0.04
21
17
404
1748
3.03
64.99
4.0
2.6
2.16
2.29
g/l
4.76
381
1631
864
5603
3.23
64.93
19.3
7.0
10.41
11.52
umol/l
2.30
847
5376
422
1875
2.98
64.65
4.0
2.6
11.77
13.18
umol/l
4.16
403
1755
291
1043
3.40
64.44
16.9
7.6
11.93
9.70
mmol/l
4.67
285
1005
268
940
3.42
61.15
11.6
5.0
0.58
0.15
%
0.61
178
247
83
107
8.29
61.06
1.5
1.4
0.45
0.44
g/l
0.04
52
82
83
107
8.29
61.06
1.5
1.4
6.39
7.31
g/l
0.51
53
83
83
107
8.29
61.06
1.5
1.4
2.15
2.90
g/l
2.44
56
82
376
1622
2.97
60.09
4.1
2.6
22.08
23.06
%
0.74
361
1527
349
1453
3.02
59.37
1.6
1.4
334.55
492.72
titre
1.96
88
327
162
411
4.43
58.82
1.6
1.2
—
—
—
0
0
625
3544
2.69
58.16
5.8
3.5
43.95
78.90
e6/l
0.64
528
2737
304
1184
3.14
58.00
8.8
3.6
7.39
7.38
ph
3.14
215
680
828
5419
2.92
57.69
22.1
7.8
1.20
1.21
mmol/l
2.32
722
4698
81
109
7.92
57.44
1.5
1.3
—
—
—
0
0
490
2479
2.71
57.19
4.4
2.7
4.30
5.40
e6/l
1.20
470
2269
293
1139
3.12
55.86
8.8
3.6
1.85
1.79
mmol/l
0.11
261
969
770
4900
2.75
55.81
18.7
7.1
1.20
1.21
mmol/l
3.05
743
4529
382
1719
2.84
55.80
3.5
2.1
29.18
29.57
s
0.68
377
1665
49
33
15.47
55.64
2.6
1.4
—
—
—
0
0
44
24
19.03
55.40
1.5
1.7
—
—
—
0
0
277
1047
3.17
55.38
3.4
2.2
369.04
376.47
nmol/l
0.17
269
988
99
173
6.17
55.03
8.8
4.5
1.40
1.48
%
0.07
93
162
263
970
3.22
54.75
6.5
3.0
63.30
66.61
g/l
7.24
253
901
101
182
5.99
54.40
1.5
1.7
0.55
0.78
g/l
0.71
66
149
559
3078
2.60
54.09
5.7
3.3
0.27
0.44
e6/l
2.47
461
2286
259
954
3.22
53.97
1.8
1.4
—
—
—
0
0
298
1195
3.02
53.56
12.6
9.5
94.77
95.58
%
1.28
289
1162
666
3998
2.60
53.55
7.0
4.1
50.00
91.29
e6/l
1.52
543
2854
226
799
3.28
50.14
6.2
2.7
—
—
—
0
0
516
2834
2.50
48.87
7.7
2.9
350.01
347.71
umol/l
0.19
484
2493
276
1121
2.93
47.93
14.3
9.9
114.30
120.88
g/l
5.27
270
1100
40
25
16.54
47.11
3.2
2.2
0.15
0.27
e9/l
—
23
10
198
684
3.29
45.35
12.5
11.3
24.26
24.36
mmol/l
0.17
193
673
113
265
4.62
45.01
2.5
1.7
—
—
—
0
0
47
44
11.10
43.75
38.9
37.3
108.80
127.65
ug/l
0.80
40
37
436
2315
2.43
43.28
14.9
5.0
—
—
—
0
0
48
48
10.39
42.70
37.6
38.4
7.62
7.05
ug/l
0.37
38
43
68
105
6.82
42.52
1.5
1.2
—
—
—
0
0
51
56
9.49
42.41
1.3
1.1
—
—
—
0
0
739
4989
2.36
41.22
19.0
15.6
1.23
1.26
inr
0.87
653
4139
704
4661
2.33
41.03
33.9
11.8
0.01
0.00
e9/l
0.56
605
3797
125
343
3.97
40.40
6.0
3.6
1.89
1.54
mg/l
3.53
118
311
135
393
3.76
40.09
9.1
3.9
60.74
64.05
mg/l
0.07
111
341
134
393
3.73
39.35
9.1
3.9
56.55
51.40
mg/l
0.17
111
343
398
2103
2.37
39.19
2.9
1.5
2.30
2.48
g/l
0.67
297
1285
242
1017
2.75
38.66
14.9
9.6
—
—
—
0
0
97
232
4.48
37.58
6.4
3.2
57.77
58.85
%
0.25
97
232
67
116
6.07
37.44
1.4
1.3
—
—
—
0
0
195
747
2.94
36.94
6.0
3.9
7.43
7.42
ph
1.40
180
631
122
357
3.71
35.86
8.6
3.7
3.63
2.54
ratio
0.26
73
212
993
7895
2.98
35.61
26.6
8.8
82.98
79.99
u/l
1.10
973
7513
63
108
6.12
35.54
1.2
1.1
—
—
—
0
0
846
6251
2.36
35.35
13.0
5.5
6.80
6.72
mmol/l
0.43
827
5962
887
6700
2.45
35.06
7.4
4.8
1228.31
1873.97
e6/l
0.19
13
105
186
715
2.91
34.91
12.1
7.8
24.45
24.54
mmol/l
0.11
178
688
580
3705
2.15
34.77
8.9
3.7
2.33
2.35
mmol/l
3.68
553
3362
116
338
3.71
34.27
2.0
1.5
0.23
0.24
g/l
0.04
109
324
118
349
3.66
34.10
2.0
1.5
1.16
1.18
g/l
0.33
113
333
413
2333
2.21
33.67
2.4
1.7
1.70
1.30
mg/l
0.74
357
1825
268
1271
2.45
32.86
2.1
1.8
—
—
—
0
0
136
453
3.27
32.62
2.3
1.8
7.49
7.12
iu/ml
0.06
35
106
99
269
3.93
32.30
3.9
2.2
121.49
128.65
g/l
1.84
81
211
200
832
2.70
32.16
10.3
3.8
1.22
1.23
mmol/l
0.99
191
717
168
641
2.90
31.82
18.5
12.2
14.97
15.90
%
3.84
163
620
84
207
4.30
31.25
8.4
4.7
2.49
2.62
mmol/l
0.16
68
138
468
2838
2.10
31.24
2.9
2.3
3.06
2.88
mg/l
0.94
432
2440
101
286
3.78
31.06
2.2
2.4
12.03
12.20
mg/l
0.06
94
267
903
7028
2.36
30.77
8.3
4.6
—
2.60
—
0
11
258
1238
2.40
30.60
5.6
2.8
7.73
8.13
umol/l
0.13
228
1109
508
3194
2.06
30.58
20.9
6.5
—
—
—
0
0
527
3363
2.05
30.40
3.8
2.7
61.61
61.06
u/l
0.05
498
3138
73
166
4.63
30.05
6.2
6.0
12.04
11.57
mg/l
0.35
68
154
500
3159
2.04
29.37
4.1
3.1
—
—
—
0
0
193
829
2.60
28.91
4.4
3.1
194.32
200.98
ng/l
0.09
179
756
70
160
4.60
28.63
4.3
2.4
1.03
0.92
%
0.67
62
118
541
3545
2.00
28.38
7.0
3.3
34.15
33.35
u/l
0.13
521
3358
218
1000
2.46
28.38
7.3
3.0
4.69
4.57
kpa
0.39
213
970
520
3389
1.98
27.43
4.7
3.2
1979.51
1272.22
ng/l
2.39
482
2920
740
5457
2.01
27.10
6.2
3.9
0.00
0.00
estimate
-0.00
207
1140
749
5556
2.01
26.85
6.3
3.9
0.00
0.30
estimate
0.54
197
1074
130
473
2.97
26.66
6.3
2.6
3.46
3.71
g/l
0.98
124
436
130
473
2.97
26.66
6.3
2.6
4.05
4.18
g/l
0.97
124
436
130
473
2.97
26.66
6.3
2.6
7.48
7.34
g/l
0.40
124
436
442
2743
2.00
26.66
8.9
4.2
89.30
88.96
%
0.10
427
2699
744
5521
2.00
26.45
6.3
3.9
12.74
4.52
estimate
0.42
210
1162
628
4411
1.94
26.12
5.1
3.5
6.28
6.22
ph
0.60
341
2446
339
1928
2.08
25.93
4.6
3.0
0.93
1.02
e6/l
0.20
201
1043
127
466
2.94
25.63
11.5
6.1
0.91
0.88
%
0.27
122
443
225
1095
2.31
25.42
2.6
2.4
0.22
0.21
g/l
0.57
206
1031
357
2083
2.04
25.37
5.8
4.1
224.82
388.40
ng/l
1.19
310
1660
135
521
2.80
24.81
1.5
1.2
—
—
—
0
0
33
42
8.06
24.36
1.2
1.1
—
—
—
0
0
70
184
3.99
23.85
1.1
1.1
—
—
—
0
0
119
446
2.86
23.05
6.7
2.6
3.16
2.98
g/l
0.96
113
409
310
1777
2.02
22.76
5.0
3.2
1.51
1.82
e6/l
0.52
176
884
159
695
2.50
22.69
1.9
1.3
201.01
248.30
u/ml
0.28
139
643
60
147
4.25
22.46
4.3
2.4
32.83
32.48
pg
0.24
60
147
249
1328
2.12
22.16
4.8
3.4
4.65
5.24
e9/l
0.54
236
1159
51
112
4.72
21.89
11.2
4.7
57.64
55.46
%
0.26
46
103
651
4790
1.84
21.79
4.8
3.1
269.30
139.52
ug/l
3.33
622
4469
111
413
2.87
21.77
6.3
2.6
9.21
10.68
g/l
1.49
104
373
71
205
3.63
21.16
1.4
1.3
66.27
61.04
mmol/l
0.46
63
172
507
3483
1.82
21.03
5.3
2.6
—
—
—
0
0
66
184
3.75
20.70
1.1
1.0
—
—
—
0
0
180
867
2.28
20.54
6.2
4.0
109.39
86.14
ng/l
2.18
163
763
202
1031
2.17
19.96
3.5
2.5
37.01
36.14
u/l
0.10
177
875
88
304
3.05
19.68
4.8
3.3
2.65
2.04
index
0.39
49
173
165
796
2.25
18.67
1.8
1.8
—
—
—
0
0
30
20
15.37
18.50
1.2
2.0
—
—
—
0
0
48
116
4.28
18.30
4.4
2.4
—
—
—
0
0
649
4919
1.74
18.22
5.9
2.9
—
—
estimate
—
0
0
25
33
7.72
17.87
1.0
1.0
—
—
—
0
0
72
234
3.22
17.84
1.2
1.2
—
—
—
0
0
46
110
4.32
17.77
1.4
1.4
—
—
—
0
0
424
2879
1.75
17.43
4.7
3.0
0.30
0.04
—
10
52
26
37
7.17
17.43
3.0
2.6
0.61
0.61
mmol/l
0.17
26
37
339
2164
1.81
17.18
4.7
3.2
2.46
2.45
mmol/l
0.48
314
1952
24
32
7.64
17.01
1.2
1.1
—
—
—
0
0
165
827
2.16
16.92
6.9
3.7
—
—
—
0
0
37
78
4.87
16.67
2.6
1.8
—
—
—
0
0
24
33
7.41
16.57
4.2
4.8
—
—
—
0
0
84
314
2.81
16.29
11.0
8.1
1.33
1.28
mmol/l
0.25
75
279
28
47
6.08
16.10
2.2
2.3
58.79
60.99
ug/l
0.05
28
47
453
3190
1.70
15.97
2.0
1.7
18.22
20.06
nmol/l
2.18
413
2696
66
218
3.15
15.93
1.6
1.3
—
—
—
0
0
550
4092
1.66
15.61
5.9
3.9
33.00
66.43
ng/l
1.35
445
3019
70
244
2.99
15.41
1.7
1.3
82.43
49.89
e6/l
0.16
56
181
609
4665
1.65
15.31
3.5
2.5
76.54
77.63
nmol/l
0.47
582
4188
76
279
2.85
15.25
1.4
1.2
—
—
—
0
0
70
248
2.94
14.98
1.7
1.4
147.94
937.82
e6/l
0.79
63
190
26
22
12.07
14.61
1.0
1.1
—
—
—
0
0
23
36
6.50
14.14
1.1
1.1
—
—
—
0
0
23
36
6.50
14.14
1.1
1.1
—
—
—
0
0
23
36
6.50
14.14
1.1
1.1
—
—
—
0
0
540
4076
1.62
13.92
2.6
2.2
—
—
—
0
0
463
3371
1.63
13.80
3.3
2.3
109.56
238.75
u/l
4.30
446
3204
22
34
6.58
13.68
2.0
1.8
—
—
—
0
0
27
52
5.29
13.48
1.4
1.7
62.77
64.85
mg/l
0.05
22
40
23
18
13.01
13.43
4.9
2.4
2.87
3.22
%
0.07
23
18
46
135
3.51
13.41
4.4
2.4
1.04
1.27
g/24h
0.21
33
80
380
2649
1.65
13.38
4.7
2.5
—
—
—
0
0
66
244
2.81
13.08
1.4
1.2
3.77
3.74
mmol/l
0.06
61
234
57
197
2.99
12.76
5.9
3.1
12.38
8.70
pmol/l
1.11
57
197
43
125
3.54
12.72
1.2
1.2
—
—
—
0
0
89
389
2.40
12.56
5.8
4.3
1.51
1.37
mmol/l
0.60
84
382
407
2922
1.61
12.55
5.9
3.3
0.03
0.05
estimate
0.13
180
907
194
1141
1.84
12.43
5.3
4.6
14.32
24.72
ug/l
0.41
157
953
34
86
4.04
12.25
1.5
1.2
4.26
0.84
u/ml
0.70
20
45
46
145
3.26
12.02
1.2
1.2
—
—
—
0
0
31
75
4.22
11.84
3.6
2.9
15.11
16.70
%
1.87
31
75
34
89
3.91
11.70
1.5
1.2
90.00
84.00
titre
—
6
15
15
5
30.36
11.66
1.0
1.0
—
—
—
0
0
529
4105
1.54
11.28
6.4
3.8
0.01
0.02
estimate
0.48
186
944
17
10
17.24
11.21
3.8
2.6
—
—
—
0
0
271
1801
1.66
11.19
1.3
1.3
28.16
12.46
u/ml
1.35
81
674
287
1947
1.63
10.89
1.3
1.3
59.07
31.26
iu/ml
2.00
103
594
25
55
4.62
10.74
2.0
1.6
—
—
—
0
0
1062
9805
2.19
10.64
56.4
17.1
26.97
25.14
mg/l
1.29
982
8133
42
136
3.17
10.53
1.1
1.4
270.32
277.98
mosm/kgh2o
1.39
37
104
70
301
2.41
10.26
1.5
1.2
5.94
2.37
u/ml
—
8
27
39
123
3.25
10.21
1.1
1.1
—
—
—
0
0
46
162
2.92
10.00
1.4
1.2
6.44
6.37
u/ml
0.01
18
78
69
300
2.38
9.88
1.5
1.2
4.56
9.08
u/ml
0.43
11
43
262
1780
1.61
9.76
1.8
1.7
1184.09
1187.46
nmol/l
0.02
215
1353
16
12
13.50
9.68
1.4
1.2
—
—
—
0
0
27
69
3.98
9.62
1.0
1.0
—
—
—
0
0
36
113
3.26
9.51
1.4
1.2
—
—
—
0
0
36
113
3.26
9.51
2.5
2.3
—
—
—
0
0
390
2913
1.51
9.50
1.7
1.4
—
—
—
0
0
67
297
2.33
9.20
1.4
1.2
—
—
—
0
0
92
472
2.03
8.78
1.4
1.3
—
—
—
0
0
401
3059
1.48
8.63
6.5
4.1
0.00
0.01
estimate
0.96
178
1061
581
4759
1.45
8.62
2.4
2.2
92.89
95.60
pmol/l
0.79
367
2534
38
131
2.97
8.61
1.6
1.7
20.43
34.70
ng/l
0.89
38
131
28
80
3.56
8.56
1.0
1.0
—
—
—
0
0
16
16
10.12
8.54
1.9
1.0
—
—
—
0
0
16
16
10.12
8.54
1.9
1.0
—
—
—
0
0
16
16
10.12
8.54
1.9
1.0
—
—
—
0
0
16
16
10.12
8.54
1.2
1.0
—
—
—
0
0
56
237
2.43
8.53
1.6
1.2
27.46
52.73
u/ml
0.59
11
22
14
11
12.87
8.38
2.4
3.2
—
—
—
0
0
83
420
2.05
8.23
5.5
3.8
265.11
327.10
mg/l
0.29
66
191
35
119
3.00
8.13
1.7
1.3
—
—
—
0
0
59
265
2.29
7.89
2.9
3.1
31.15
34.30
umol/l
0.64
52
234
148
915
1.71
7.85
2.4
2.5
8.12
7.72
ug/l
0.09
133
830
193
1279
1.61
7.83
3.0
2.6
177.01
130.45
ug/g
0.78
157
1036
14
13
10.89
7.80
1.7
1.2
—
—
—
0
0
28
86
3.31
7.69
1.3
1.1
129.71
104.07
pmol/l
0.86
28
86
38
140
2.77
7.66
1.6
1.4
2303.14
1629.30
e6/l
0.42
29
91
97
532
1.90
7.66
6.4
4.0
—
—
—
0
0
67
322
2.15
7.62
1.6
1.4
235.22
284.17
ug/g
1.21
41
192
44
176
2.56
7.57
1.1
1.1
45.04
20.00
au/ml
—
5
46
17
24
7.17
7.49
1.4
1.4
—
—
—
0
0
27
83
3.31
7.41
1.4
1.2
—
—
—
0
0
103
583
1.84
7.38
2.8
3.7
4.06
4.55
pmol/l
4.80
90
511
17
25
6.88
7.30
1.4
1.1
0.44
3.68
mmol/l
0.68
12
16
19
33
5.84
7.23
2.4
2.0
—
—
—
0
0
92
507
1.89
7.17
2.4
2.4
—
—
—
0
0
13
13
10.10
7.04
1.2
1.0
—
—
—
0
0
13
13
10.10
7.04
1.2
1.0
—
—
—
0
0
27
87
3.15
6.89
1.7
1.3
37.25
31.20
%
0.34
20
60
58
276
2.16
6.78
1.3
1.3
223.43
236.76
miu/ml
0.08
13
124
59
286
2.12
6.59
1.7
1.4
13.68
9.03
u/l
1.20
44
220
24
74
3.29
6.58
1.4
1.6
5.63
5.95
u/l
0.13
18
62
766
6776
1.40
6.38
5.0
3.4
69.62
51.88
u/l
3.79
731
6368
115
705
1.70
6.29
2.3
2.5
24.73
18.57
au/ml
0.28
11
63
46
210
2.24
5.98
1.7
1.6
—
—
—
0
0
16
31
5.22
5.71
1.4
1.4
2.19
3.47
mmol/l
1.47
16
26
41
182
2.30
5.70
1.5
1.1
—
—
—
0
0
41
183
2.29
5.63
1.5
1.1
—
—
—
0
0
14
24
5.89
5.54
3.8
2.4
—
—
—
0
0
23
78
2.99
5.43
1.0
1.1
61.58
38.06
mg/l
0.87
18
67
34
144
2.40
5.27
1.2
1.2
—
—
—
0
0
30
121
2.52
5.15
1.8
1.3
54565.42
89619.23
e6/l
0.20
19
62
22
76
2.93
5.05
3.7
2.9
9.04
8.19
mmol/l
0.31
22
76
77
451
1.76
4.98
4.2
3.7
404.17
3380.57
u/ml
0.75
66
393
11
16
6.93
4.96
3.5
2.6
—
—
—
0
0
13
24
5.47
4.92
1.2
1.1
—
—
—
0
0
44
216
2.08
4.83
3.1
3.3
0.84
0.82
nmol/l
0.09
36
178
1060
10119
1.66
4.74
56.8
20.5
4.01
3.98
mmol/l
3.08
1055
9912
7
5
14.07
4.58
5.4
3.6
—
—
—
0
0
199
1490
1.41
4.36
1.4
1.2
—
—
—
0
0
1079
10376
1.72
4.32
33.6
12.8
27.12
26.52
u/l
0.56
1070
10096
18
61
2.98
4.29
1.1
1.2
0.81
0.49
ratio
—
10
38
17
57
3.01
4.13
1.1
1.2
—
—
—
0
0
166
1224
1.42
3.97
1.4
1.4
—
—
—
0
0
27
118
2.32
3.96
2.0
1.6
56.06
60.86
%
0.24
18
78
15
48
3.15
3.94
2.1
1.4
48.79
61.31
%
0.69
15
39
21
82
2.59
3.90
1.6
1.3
—
—
—
0
0
10
19
5.30
3.83
4.0
2.6
—
—
—
0
0
9
15
6.04
3.82
10.9
10.0
5.70
5.53
mmol/l
—
9
15
7
8
8.79
3.77
1.3
1.3
—
—
—
0
0
11
24
4.62
3.75
2.5
2.0
—
—
—
0
0
55
320
1.76
3.70
1.4
1.2
113.33
99.00
titre
—
9
30
298
2433
1.30
3.67
6.1
4.1
1.02
1.02
kg/l
0.66
230
1622
43
236
1.85
3.51
3.6
2.2
4022.05
4876.84
u/l
0.08
17
97
8
13
6.19
3.50
1.6
1.8
—
—
—
0
0
51
296
1.76
3.48
2.1
1.6
8920.94
12666.91
e6/l
0.43
36
211
20
84
2.41
3.24
1.3
1.1
—
—
—
0
0
13
40
3.28
3.14
5.2
2.9
35.26
230.45
ug/l
0.44
13
33
13
44
2.98
3.14
2.2
1.4
4.46
3.25
%
0.15
13
37
9
20
4.53
3.11
5.4
7.7
5.22
5.25
kpa
—
9
20
825
7690
1.26
3.09
4.9
4.3
14.82
14.85
pmol/l
0.13
768
7031
20
86
2.35
3.09
3.3
4.9
64.92
40.39
u/ml
—
6
27
11
30
3.69
3.09
1.1
1.3
25.91
27.23
s
0.46
11
30
10
25
4.03
3.09
1.1
1.1
—
—
—
0
0
6
8
7.53
3.05
1.0
1.0
—
—
—
0
0
5
5
10.04
2.98
1.0
1.0
—
—
—
0
0
1045
10079
1.43
2.92
39.2
15.2
—
—
—
0
0
20
89
2.27
2.88
1.3
1.1
—
—
—
0
0
40
230
1.77
2.86
1.4
1.3
—
—
—
0
0
14
53
2.66
2.80
4.1
1.4
25.79
30.65
umol/l
0.94
14
48
44
710
0.60
2.77
1.3
1.8
3.35
3.46
mmol/l
0.25
31
527
5
6
8.36
2.75
1.0
1.0
—
—
—
0
0
5
6
8.36
2.75
1.0
1.0
—
—
—
0
0
5
6
8.36
2.75
1.0
1.0
—
—
—
0
0
5
6
8.36
2.75
1.0
1.3
—
—
—
0
0
5
6
8.36
2.75
1.0
1.0
—
—
—
0
0
5
6
8.36
2.75
1.0
1.0
—
—
—
0
0
265
2211
1.26
2.68
1.7
1.7
90598747.72
26608936.32
pmol/l
0.49
234
1834
25
126
2.01
2.67
2.1
1.4
—
—
—
0
0
12
41
2.95
2.62
1.2
1.1
—
—
—
0
0
22
422
0.51
2.57
1.5
1.7
—
—
—
0
0
12
42
2.88
2.55
2.2
1.2
21.92
30.20
%
0.40
12
37
278
2351
1.24
2.48
1.3
1.3
0.99
1.59
u/ml
0.95
61
638
176
1413
1.29
2.43
1.5
1.3
—
—
—
0
0
24
124
1.96
2.41
2.4
1.6
—
—
—
0
0
26
139
1.89
2.38
1.2
1.1
—
—
—
0
0
41
252
1.65
2.36
6.0
4.5
—
—
—
0
0
16
71
2.27
2.35
1.1
1.2
289.33
378.90
nmol/l
—
9
60
23
119
1.95
2.31
15.3
1.8
8.76
10.57
%
1.39
23
119
18
85
2.14
2.29
2.5
1.9
0.92
1.82
u/field
0.93
12
50
43
270
1.62
2.29
1.5
1.9
78.16
3.93
iu/l
0.46
12
103
1090
10650
1.52
2.28
72.1
25.9
235.31
247.87
e9/l
6.31
1082
10453
6
13
4.63
2.27
1.0
1.0
16.53
18.72
g/l
—
6
13
1090
10653
1.51
2.24
71.9
25.9
4.20
4.49
e12/l
44.76
1082
10423
59
401
1.50
2.23
1.6
1.4
34.94
27.62
iu/l
0.69
47
337
1090
10654
1.51
2.23
72.0
25.9
7.31
6.77
e9/l
4.71
1080
10422
23
121
1.92
2.22
1.4
1.3
—
—
—
0
0
130
1016
1.32
2.20
2.6
2.2
0.10
0.03
estimate
0.33
31
198
24
129
1.88
2.18
1.4
1.3
—
—
—
0
0
7
19
3.70
2.15
1.0
1.0
—
—
—
0
0
14
61
2.31
2.15
3.1
1.9
—
41.60
—
0
6
11
43
2.57
2.08
2.5
1.3
—
—
—
0
0
5
10
5.02
2.07
1.2
1.0
—
—
—
0
0
13
57
2.30
1.98
2.2
1.2
144.00
145.24
nmol/l
0.03
13
57
9
201
0.44
1.97
1.2
1.7
—
—
—
0
0
10
39
2.58
1.94
1.2
1.2
—
21.33
u/ml
—
0
6
6
16
3.76
1.93
4.7
3.8
—
—
—
0
0
13
59
2.22
1.84
1.2
1.3
4.98
5.84
ug/l
0.47
13
51
17
87
1.97
1.80
1.0
1.1
—
2.02
—
0
14
45
304
1.50
1.80
1.4
1.5
230.26
285.89
mu/l
1.11
39
282
60
822
0.71
1.77
1.3
1.4
—
—
—
0
0
104
815
1.30
1.76
1.2
1.2
—
—
—
0
0
8
31
2.59
1.66
1.9
1.4
—
—
—
0
0
14
69
2.04
1.65
1.2
1.2
—
—
—
0
0
15
77
1.96
1.59
2.5
2.2
20.39
19.82
nmol/l
0.08
15
71
86
671
1.30
1.53
1.3
1.2
125.30
141.62
u/ml
0.15
26
265
402
3686
1.14
1.32
4.7
3.7
—
0.69
—
0
13
10
48
2.09
1.28
1.1
1.1
—
—
—
0
0
415
3823
1.13
1.26
5.1
3.5
6.90
7.69
mmol/l
3.26
369
3246
18
108
1.68
1.22
1.5
1.3
15183.00
199174.97
e6/l
1.28
13
76
61
474
1.30
1.17
1.1
1.1
—
122.38
—
0
13
6
130
0.46
1.16
1.5
2.5
—
—
—
0
0
20
127
1.59
1.12
1.7
1.4
0.29
0.32
nmol/l
0.15
15
97
99
823
1.22
1.09
3.2
2.4
6.19
6.06
ph
0.70
75
556
25
169
1.49
1.08
1.6
1.7
—
—
—
0
0
940
9154
1.15
1.06
6.0
5.3
2.05
1.95
mu/l
0.53
882
8432
108
910
1.21
1.05
1.5
1.4
—
—
—
0
0
15
90
1.68
1.04
3.7
2.4
5.39
7.94
umol/l
—
10
67
22
319
0.68
0.98
18.4
11.5
—
—
—
0
0
10
54
1.86
0.96
1.2
1.5
—
—
—
0
0
46
356
1.30
0.94
1.7
1.6
9.41
13.27
u/ml
—
8
72
15
94
1.60
0.90
1.0
1.1
—
—
—
0
0
388
3623
1.11
0.89
5.2
3.6
82.12
47.62
mg/l
1.90
290
2357
20
135
1.49
0.89
1.3
1.2
—
—
—
0
0
395
3692
1.11
0.89
5.8
4.3
16.10
8.91
mg/mmol
1.93
285
2327
18
120
1.51
0.85
2.5
1.8
—
—
—
0
0
0
24
0.00
0.79
0.0
1.0
—
6.26
—
0
16
12
74
1.63
0.78
1.5
1.7
14.70
13.47
umol/l
0.18
12
69
13
82
1.59
0.78
1.3
2.5
20.63
33.12
mg/l
—
8
57
58
476
1.23
0.77
1.3
1.7
0.43
0.36
mg/l
0.29
29
228
20
140
1.44
0.77
5.7
1.7
—
—
—
0
0
44
351
1.26
0.75
1.0
1.1
—
—
—
0
0
9
54
1.67
0.74
4.2
1.4
32.02
26.62
umol/l
—
9
46
15
100
1.51
0.73
2.3
2.6
—
—
—
0
0
5
26
1.93
0.70
1.2
1.2
—
—
—
0
0
9
58
1.56
0.70
1.4
1.4
131.33
164.62
pmol/l
—
9
58
112
987
1.15
0.69
2.4
2.3
12.35
13.11
nmol/l
0.34
98
886
357
3783
0.92
0.67
3.7
3.3
—
—
—
0
0
62
526
1.19
0.62
2.8
2.2
0.00
1.58
estimate
0.50
21
159
5
30
1.67
0.61
1.4
1.2
43.48
27.09
nmol/l
—
5
25
214
2307
0.91
0.59
2.4
3.4
0.64
0.75
ug/l
1.32
143
1519
57
483
1.19
0.59
2.2
1.9
—
—
—
0
0
402
3825
1.08
0.59
4.8
5.7
3.19
2.44
ug/l
0.58
363
3446
33
266
1.25
0.55
2.4
2.5
172.40
95.21
ug/min
0.62
24
153
15
107
1.41
0.55
1.1
1.2
—
—
—
0
0
24
306
0.78
0.54
1.2
1.2
1.50
1.52
g/l
0.11
24
306
6
38
1.58
0.54
2.7
3.2
—
—
—
0
0
17
126
1.35
0.51
1.1
1.3
0.16
0.19
nmol/l
—
10
97
23
290
0.79
0.49
1.1
1.1
0.74
0.68
ratio
—
5
44
7
45
1.56
0.49
3.9
2.0
37.83
40.16
g/l
—
7
45
52
447
1.17
0.48
2.4
2.7
—
—
—
0
0
20
256
0.78
0.48
1.0
1.2
—
—
—
0
0
7
47
1.49
0.47
1.3
1.3
297.86
179.80
mmol/24h
—
7
47
0
17
0.00
0.40
0.0
2.3
—
2.91
—
0
8
5
36
1.39
0.38
3.0
1.8
—
—
—
0
0
5
36
1.39
0.38
1.0
1.0
—
15.44
—
0
6
16
125
1.28
0.37
1.1
1.1
0.53
4.24
u/ml
—
6
62
986
9958
0.93
0.36
6.0
6.0
2.61
2.67
mmol/l
1.53
918
9252
39
338
1.16
0.35
1.7
1.8
46.36
40.12
nmol/l
0.69
39
326
6
43
1.40
0.35
2.7
2.9
—
—
—
0
0
6
44
1.37
0.34
4.5
2.5
53.23
49.24
umol/l
—
6
38
6
46
1.31
0.33
1.0
1.3
6.83
10.50
mm/h
—
6
46
76
694
1.10
0.32
1.3
1.3
—
—
—
0
0
26
228
1.14
0.23
5.4
2.0
—
—
—
0
0
16
135
1.19
0.21
1.0
1.1
0.87
2.60
u/ml
—
6
72
0
12
0.00
0.21
0.0
1.0
—
0.24
—
0
5
14
166
0.84
0.20
1.1
1.1
2.06
5.53
u/ml
—
8
94
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
5.31
—
0
14
6
50
1.20
0.19
1.2
1.1
2377.83
1565.30
miu/ml
—
6
50
939
9325
1.04
0.18
4.8
4.4
1.37
1.30
mmol/l
2.09
865
8575
27
300
0.90
0.18
1.1
1.1
—
—
—
0
0
117
1121
1.05
0.17
1.6
1.6
—
—
—
0
0
29
317
0.91
0.15
4.6
1.5
—
—
—
0
0
14
121
1.16
0.15
1.2
1.2
1.42
1.51
nmol/l
0.09
14
109
13
112
1.16
0.14
1.3
1.3
41.47
27.70
u/l
0.77
13
97
97
1011
0.96
0.14
12.8
4.5
7.39
7.35
ph
1.93
88
733
14
160
0.87
0.14
1.1
1.1
0.18
2.89
u/ml
—
6
74
14
124
1.13
0.11
1.1
1.3
—
—
nmol/l
—
0
0
30
322
0.93
0.11
1.9
1.2
0.93
0.90
g/l
0.30
30
322
973
9767
0.97
0.10
5.3
5.2
1.41
1.45
mmol/l
1.96
903
9044
22
204
1.08
0.08
6.2
3.8
36.31
24.34
mg/l
0.66
16
139
17
156
1.09
0.08
1.1
1.1
0.23
1.51
u/ml
—
8
87
25
266
0.94
0.07
5.0
1.4
—
—
—
0
0
437
4331
1.01
0.07
2.1
2.0
1.44
1.35
mmol/l
1.54
376
3619
7
81
0.86
0.07
1.3
1.6
0.76
1.21
promille
—
7
68
12
132
0.91
0.06
1.1
1.2
—
—
—
0
0
979
9815
0.98
0.06
5.5
5.3
4.52
4.57
mmol/l
1.06
917
9151
47
485
0.97
0.05
1.0
1.1
—
—
—
0
0
33
343
0.96
0.05
4.2
1.5
—
—
—
0
0
20
190
1.05
0.04
1.1
1.1
0.62
2.07
u/ml
1.48
11
111
12
128
0.94
0.02
1.6
1.7
—
—
—
0
0
945
9438
1.01
0.02
7.2
6.7
39.34
39.50
mmol/mol
0.23
898
8830
12
126
0.95
0.00
1.6
1.6
—
—
—
0
0
34
344
0.99
0.00
4.2
1.5
—
—
—
0
0
34
342
0.99
0.00
3.9
1.5
—
—
—
0
0
34
339
1.00
0.00
4.1
1.5
—
—
—
0
0
958
9581
1.00
0.00
5.8
5.4
6.00
5.98
mmol/l
0.16
894
8786
7
71
0.99
-0.00
1.6
1.4
93.00
80.01
umol/l
—
7
71
0
5
0.00
-0.00
0.0
1.2
—
76.94
—
0
5
0
6
0.00
-0.00
0.0
2.3
—
31.67
—
0
6
0
5
0.00
-0.00
0.0
5.2
—
392.60
—
0
5
0
8
0.00
-0.00
0.0
1.8
—
252.11
—
0
8
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
69
1.01
-0.00
1.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.0
—
0.61
—
0
8
0
5
0.00
-0.00
0.0
1.6
—
383.40
—
0
5
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
86.13
—
0
8
8
84
0.95
-0.00
1.1
2.4
8.18
6.63
mmol/l
—
8
54

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_PROTOZOAL and mortality.

Females

Parameter HR [95% CI] p-value
AB1_PROTOZOAL 3.997 [3.21, 4.98] < 0.001
Birth year 0.994 [0.99, 1.0] 0.171

During the follow-up period (1.1.1998 — 31.12.2019), 470 out of 1914 females with AB1_PROTOZOAL died.

Males

Parameter HR [95% CI] p-value
AB1_PROTOZOAL 3.555 [2.88, 4.38] < 0.001
Birth year 0.981 [0.97, 0.99] < 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 575 out of 2159 males with AB1_PROTOZOAL died.

Mortality risk

Mortality risk for people of age

years, who have AB1_PROTOZOAL.

N-year risk Females Males
1 0.377% 0.561%
5 2.125% 3.161%
10 5.209% 8.234%
15 9.94% 14.814%
20 17.521% 24.247%

Relationships between endpoints

↥

Index endpoint: AB1_PROTOZOAL – Protozoal diseases

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data